Basic info
Industry
biotechnology research
Sectors
Translation Enhancers
Biotechnology
Novel Modality
Neurodegeneration
RNA Therapeutics
Rare Disease
Life Science
Date founded
2020
Funding rounds raised
Total raised
$13M
from 6 investors over 6 rounds
T
Transine Therapeutics raised $5.8M on May 31, 2022
Investors: The Dementia Discovery Fund and Epidarex Capital
T
Transine Therapeutics raised $13M on June 1, 2021
Investors: Takeda UK Limited and The Dementia Discovery Fund
T
Transine Therapeutics raised undisclosed on January 1, 2020
Investors: The Dementia Discovery Fund and Takeda UK Limited